Stock listing
TPEx:6572 PlexBio Co., Ltd. (博錸) 股價
Follow PlexBio Co., Ltd. into a list and get an email when it puts out news.
Share price · TPEX:6572
$5.02 TWD -0.75 (-13.0%)
Close on Nov 20, 2026
- Day range
- $4.76 – $5.18 TWDNov 20, 2026
- Volume
- 243,683 sharesNov 20, 2026
- Market cap
- $520.3M TWDAt the close on Nov 20, 2026 · price × 103.6M shares outstanding
- Traded on an average day
- $1.23M TWDMedian day 83,848 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6572 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $5.02 | -0.75 | -13.0% | $5.18 | $5.18 | $4.76 | 243,683 | |
| $5.77 | -0.27 | -4.5% | $6.05 | $6.05 | $5.50 | 101,070 | |
| $6.04 | 0.00 | 0.0% | $6.04 | $6.04 | $5.83 | 6,743 | |
| $6.04 | -0.24 | -3.8% | $6.28 | $6.28 | $5.77 | 157,383 | |
| $6.28 | 0.00 | 0.0% | $5.98 | $6.28 | $5.98 | 20,325 | |
| $6.28 | 0.00 | 0.0% | $6.28 | $6.28 | $5.99 | 25,749 | |
| $6.28 | +0.32 | +5.4% | $6.08 | $6.28 | $5.98 | 23,166 | |
| $5.96 | -0.51 | -7.9% | $6.47 | $6.47 | $5.96 | 37,351 | |
| $6.47 | +0.39 | +6.4% | $6.10 | $6.47 | $6.10 | 27,883 | |
| $6.08 | +0.28 | +4.8% | $5.42 | $6.08 | $5.20 | 120,883 | |
| $5.80 | -0.25 | -4.1% | $6.31 | $6.31 | $5.52 | 269,275 | |
| $6.05 | -0.25 | -4.0% | $6.30 | $6.31 | $5.82 | 191,315 | |
| $6.30 | +0.08 | +1.3% | $6.50 | $6.52 | $6.00 | 278,581 | |
| $6.22 | -0.13 | -2.0% | $6.50 | $6.50 | $6.22 | 44,123 | |
| $6.35 | -0.34 | -5.1% | $6.69 | $6.69 | $6.21 | 224,970 | |
| $6.69 | -0.10 | -1.5% | $6.79 | $6.79 | $6.37 | 61,637 | |
| $6.79 | +0.09 | +1.3% | $6.70 | $6.79 | $6.47 | 106,268 | |
| $6.70 | -0.14 | -2.0% | $6.52 | $6.85 | $6.51 | 104,677 | |
| $6.84 | +0.32 | +4.9% | $6.84 | $6.84 | $6.84 | 0 | |
| $6.52 | -0.35 | -5.1% | $6.87 | $6.97 | $6.52 | 65,154 | |
| $6.87 | +0.05 | +0.7% | $6.92 | $6.92 | $6.59 | 36,261 | |
| $6.82 | -0.30 | -4.2% | $7.12 | $7.14 | $6.57 | 75,710 | |
| $7.12 | +0.13 | +1.9% | $6.99 | $7.12 | $6.60 | 83,265 | |
| $6.99 | -0.05 | -0.7% | $6.91 | $6.99 | $6.65 | 12,221 | |
| $7.04 | -0.10 | -1.4% | $6.81 | $7.05 | $6.70 | 135,110 | |
| $7.14 | +0.09 | +1.3% | $7.14 | $7.14 | $6.81 | 26,856 | |
| $7.05 | -0.09 | -1.3% | $6.81 | $7.14 | $6.64 | 75,045 | |
| $7.14 | -0.53 | -6.9% | $7.57 | $7.57 | $6.45 | 279,708 | |
| $7.67 | +0.65 | +9.3% | $7.09 | $8.02 | $7.07 | 404,828 | |
| $7.02 | +0.01 | +0.1% | $7.30 | $7.30 | $6.98 | 88,414 | |
| $7.01 | -0.30 | -4.1% | $7.31 | $7.31 | $6.97 | 89,471 | |
| $7.31 | +0.33 | +4.7% | $6.98 | $7.31 | $6.89 | 170,374 | |
| $6.98 | 0.00 | 0.0% | $6.95 | $6.98 | $6.89 | 126,488 | |
| $6.98 | -0.01 | -0.1% | $7.00 | $7.18 | $6.85 | 107,264 | |
| $6.99 | -0.12 | -1.7% | $6.78 | $7.03 | $6.78 | 100,389 | |
| $7.11 | 0.00 | 0.0% | $7.11 | $7.11 | $6.78 | 69,679 | |
| $7.11 | +0.02 | +0.3% | $7.09 | $7.11 | $6.78 | 148,132 | |
| $7.09 | +0.21 | +3.1% | $7.00 | $7.10 | $6.83 | 77,200 | |
| $6.88 | +0.07 | +1.0% | $7.00 | $7.14 | $6.81 | 80,527 | |
| $6.81 | -0.46 | -6.3% | $7.28 | $7.28 | $6.75 | 49,766 | |
| $7.27 | 0.00 | 0.0% | $7.02 | $7.27 | $6.92 | 41,874 | |
| $7.27 | 0.00 | 0.0% | $7.27 | $7.27 | $6.93 | 84,430 | |
| $7.27 | +0.30 | +4.3% | $7.22 | $7.27 | $6.93 | 18,979 | |
| $6.97 | -0.10 | -1.4% | $6.76 | $7.25 | $6.76 | 69,081 | |
| $7.07 | -0.22 | -3.0% | $7.29 | $7.35 | $6.76 | 144,194 | |
| $7.29 | +0.09 | +1.2% | $7.18 | $7.53 | $6.85 | 269,848 | |
| $7.20 | -1.29 | -15.2% | $8.50 | $8.50 | $6.71 | 1,386,169 | |
| $8.49 | 0.00 | 0.0% | $8.47 | $10.70 | $8.08 | 2,357,909 | |
| $8.49 | +0.99 | +13.2% | $7.25 | $8.83 | $7.23 | 531,121 | |
| $7.50 | -0.17 | -2.2% | $7.31 | $7.70 | $7.30 | 48,052 | |
| $7.67 | -0.03 | -0.4% | $7.89 | $7.89 | $7.09 | 120,750 | |
| $7.70 | +0.08 | +1.0% | $8.01 | $8.01 | $7.57 | 156,747 | |
| $7.62 | -0.46 | -5.7% | $8.02 | $8.03 | $7.61 | 50,345 | |
| $8.08 | -0.01 | -0.1% | $8.08 | $8.09 | $7.71 | 31,233 | |
| $8.09 | +0.26 | +3.3% | $7.82 | $8.40 | $7.50 | 36,993 | |
| $7.83 | -0.02 | -0.3% | $7.52 | $7.85 | $7.48 | 49,741 | |
| $7.85 | +0.04 | +0.5% | $7.81 | $8.09 | $7.40 | 87,622 | |
| $7.81 | +0.13 | +1.7% | $7.78 | $7.81 | $7.61 | 36,306 | |
| $7.68 | +0.01 | +0.1% | $7.66 | $7.68 | $7.31 | 27,213 | |
| $7.67 | -0.05 | -0.6% | $7.86 | $7.87 | $7.14 | 57,402 | |
| $7.72 | -0.01 | -0.1% | $7.41 | $8.02 | $7.41 | 191,658 | |
| $7.73 | -0.10 | -1.3% | $7.84 | $8.21 | $7.60 | 154,436 |
- Ticker
- TPEx:6572
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- TPEx
- Currency
- TWD
PlexBio Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
Valuation
EV/sales 1.9× against a median of 3.6×: 5th lowest of 10 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $237.1M TWD
- P/E
- Loss
- EV/sales
- 1.9×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.8×
- Gross margin
- 31.8%
- Operating margin
- −51.6%
- Net margin
- −49.1%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| PlexBio Co., Ltd. · TPEX:6572 | US$15.79M | US$7.19M | n/a | 1.9× | n/a | 1.8× | −49.1% | 0.0× | n/a |
| Nexsen Limited · ASX:NXN | US$18.05M | US$15.08M | n/a | n/a | n/a | 4.8× | n/a | 0.0× | n/a |
| Genedrive PLC · LSE:GDR | US$17.85M | US$18.00M | n/a | 18.0× | n/a | n/a | −684.7% | n/a | n/a |
| Microba Life Sciences Limited · ASX:MAP | US$17.70M | US$15.16M | n/a | 1.6× | n/a | 1.1× | −140.4% | 0.2× | n/a |
| Biosynex SA · EURONEXT:ALBIO | US$15.37M | US$73.75M | n/a | 0.7× | 2.3× | 0.4× | −61.1% | 1.9× | n/a |
| Verici DX PLC · LSE:VRCI | US$15.25M | US$13.61M | n/a | 3.6× | n/a | 2.6× | −189.2% | 0.1× | n/a |
| Medicon Hellas · ATHEX:MEDIC | US$14.99M | US$7.66M | 7.7× | 0.4× | 1.9× | 0.7× | 9.8% | 0.0× | n/a |
| Pharmigene, Inc. · TPEX:7595 | US$14.70M | US$29.38M | n/a | 4.8× | n/a | 1.9× | −36.5% | 2.2× | n/a |
| BCAL Diagnostics Limited · ASX:BDX | US$14.64M | US$18.17M | n/a | 150× | n/a | n/a | n/a | n/a | n/a |
| Rhythm Biosciences Limited · ASX:RHY | US$14.05M | US$11.94M | n/a | 211× | n/a | 5.8× | n/a | 0.1× | n/a |
| Noul Co Ltd. · KRX:376930 | US$14.03M | US$6.23M | n/a | 1.6× | n/a | 1.1× | −389.6% | 0.0× | n/a |
| Median of the others | US$15.12M | US$15.12M | 7.7× | 3.6× | 2.0× | 1.5× | −140.4% | 0.1× |
Team and board
Officers
| Officer | Role |
|---|---|
| Lipi Yeh | CFO |
| Dean Tsao | Chairman/President |
| Jason Lei | Senior Vice President of Research & Development |
Board
| Director | Role |
|---|---|
| Dean Tsao | Chairman/President |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 127.1M | 128.1M | 167.2M | 191.2M | 124.9M | 101.3M | |
| Cost of revenue | 86.7M | 78.8M | 104.7M | 132.2M | 86.4M | 59.7M | |
| Gross profit | 40.4M | 49.3M | 62.5M | 59.0M | 38.6M | 41.7M | |
| Research and development | 52.5M | 69.3M | 63.0M | 72.6M | 113.3M | 113.4M | |
| Selling, general and administrative | 53.6M | 39.3M | 38.7M | 37.4M | 40.5M | 44.2M | |
| Operating income | -65.6M | -79.5M | -64.2M | -66.9M | -135.3M | -148.3M | |
| Depreciation and amortization | 16.5M | 18.8M | 18.0M | 20.1M | 24.5M | 25.3M | |
| EBITDA | -49.2M | -60.8M | -46.2M | -46.9M | -110.7M | -123.0M | |
| Interest expense | 265.0K | 164.0K | 263.0K | 167.0K | 226.0K | 234.0K | 386.0K |
| Income before tax | -62.5M | -61.6M | -58.5M | -53.1M | -131.6M | -141.1M | |
| Net income | -62.5M | -61.6M | -58.5M | -53.1M | -131.6M | -141.1M | |
| Earnings per share, basic | -0.60 | -0.59 | -0.56 | -0.51 | -1.27 | -1.37 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 191.0M | 266.5M | 278.9M | 310.4M | 348.3M | 315.5M | |
| Short-term investments | 137.4M | 149.0M | 149.0M | 169.0M | 213.5M | 350.7M | |
| Receivables | 1.39M | 3.98M | 537.0K | 2.20M | 5.32M | 9.54M | 20.2M |
| Inventory | 50.3M | 37.3M | 30.3M | 37.6M | 50.3M | 42.7M | |
| Current assets | 416.9M | 536.3M | 478.6M | 547.9M | 684.9M | 771.3M | |
| Total assets | 446.6M | 572.4M | 516.7M | 582.2M | 732.8M | 823.2M | |
| Accounts payable | 3.08M | 9.86M | 2.46M | 2.77M | 3.26M | 9.11M | 4.59M |
| Current liabilities | 116.6M | 168.9M | 54.5M | 46.3M | 144.6M | 93.4M | |
| Total debt | 5.67M | 10.9M | 6.02M | 9.15M | 9.49M | 494.0K | |
| Total liabilities | 136.1M | 198.0M | 92.3M | 102.7M | 198.5M | 160.7M | |
| Shareholders' equity | 310.4M | 374.4M | 424.4M | 479.4M | 534.3M | 662.5M | |
| Shares outstanding | 103.6M | 104.5M | 104.5M | 103.6M | 103.5M | 103.0M | 79.9M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -79.1M | -5.06M | -29.3M | -71.4M | -84.3M | -110.8M | |
| Capital spending | -413.0K | -3.59M | -3.07M | -2.02M | -11.6M | -6.49M | 0 |
| Free cash flow | -79.5M | -8.64M | -32.3M | -73.5M | -95.9M | -117.3M | |
| Cash from investing | 809.0K | 16.9M | 42.1M | 126.3M | -24.1M | ||
| Cash from financing | -8.66M | -19.0M | -8.88M | -8.91M | 3.35M | ||
| Change in cash | -75.5M | -12.3M | -31.5M | -37.9M | 32.8M | -131.1M |
Cap table
Built by 6ix from PlexBio Co., Ltd.’s releases
- Common shares
- 103,649,000
- Fully diluted
- 103,649,000
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 103,649,000 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 103,649,000 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dean Tsao | Chairman/President · Since at least Nov 5, 2026 |
| Jason Lei | Senior Vice President of Research & Development · Since at least Nov 5, 2026 |
| Lipi Yeh | CFO · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about PlexBio Co., Ltd.